Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 3.661\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CC1=NNC(=O)C1CCC(=O)N/N=C\c1ccccc1[N+](=O)[O-]
b.) O=C(N/N=C/c1cccnc1)C(O)c1ccccc1
c.) Cc1sc2nc(CSCC(=O)N(C)c3ccccc3)[nH]c(=O)c2c1C
Answer: c. Cc1sc2nc(CSCC(=O)N(C)c3ccccc3)[nH]c(=O)c2c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1sc2nc(CSCC(=O)N(C)c3ccccc3)[nH]c(=O)c2c1C
Cc1sc2nc(CSCC(=O)N(C)c3ccccc3)[nH]c(=O)c2c1C
2-[(5,6-dimethyl-4-oxo-3H-thieno[2,3-d]pyrimidin-2-yl)methylsulfanyl]-N-methyl-N-phenylacetamide